Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
3 raisons identifiées
Plateau technique de référence
Assistance publique – Hôpitaux de Paris (APHP) — équipements et expertise pointus pour les cas complexes
Auteur de référence en rhumatologie
29 articles scientifiques publiés — un praticien à la pointe de la recherche
Délais de RDV courts dans la région
336.2 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.
Influence scientifique
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
43
43 articles ont été cités au moins 43fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.
h-index
Total citations reçues
6 376
Nombre de fois où d'autres équipes ont mentionné ses publications dans leurs propres travaux.
Publications totales
235
Articles, revues et chapitres référencés dans les bases académiques internationales.
Articles influents
87
Publications ayant marqué leur domaine — chacune citée au moins 10 fois par d'autres chercheurs.
i10-index
Thématiques principales
Affiliations FR : Inserm · Université Paris Cité · Sorbonne Paris Cité
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
Intracerebral Hemorrhage in Patients With CADASIL: Additive Impact of the NOTCH3 R544C Variant and Hypertension?
2025ArticleStroke
Transcranial ultrasound localization microscopy in moyamoya patients using a clinical ultrasound system
2025ArticleTheranostics
Gaps and overlaps between sustainability science and the environmental humanities
2025ArticleSustainability Science
Determining Clinical Disease Progression in Symptomatic Patients With CADASIL
2025ArticleNeurology
PFMG2025–integrating genomic medicine into the national healthcare system in France
2025ArticleThe Lancet Regional Health - Europe
Moyamoya Angiopathy and Antiphospholipid Antibodies: A Coincidental Association?
2024ArticleStroke
CADA-PRO, a patient questionnaire measuring key cognitive, motor, emotional and behavioral Outcomes in CADASIL
2024ArticleStroke
Prevalence and characteristics of vascular cognitive impairment in a European cohort of adult patients with Moyamoya angiopathy
2024ArticleJournal of Neurology
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
GHU APHP NUP SITE LARIBOISIERE
2 R AMBROISE PARE, 75475 PARIS CEDEX 10
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Cerebrovascular diseases (Basel, Switzerland) · 2016
<b><i>Background:</i></b> The pathogenesis of moyamoya disease (MMD) is still unknown. The detection of inflammatory molecules such as cytokines, chemokines and growth factors in MMD patients' biological fluids supports the hypothesis that an abnormal angiogenesis is implicated in MMD pathogenesis. However, it is unclear whether these anomalies are the consequences of the disease or rather causal factors as well as these mechanisms remain insufficient to explain the pathophysiology of MMD. The presence of a family history in about 9-15% of Asian patients, the highly variable incidence rate between different ethnic and sex groups and the age of onset support the role of genetic factors in MMD pathogenesis. However, although some genetic loci have been associated with MMD, few of them have been replicated in independent series. Recently, <i>RNF213</i> gene was shown to be strongly associated with MMD occurrence with a founder effect in East Asian patients. However, the mechanisms leading from <i>RNF213</i> mutations to MMD clinical features are still unknown. <b><i>Summary:</i></b> The research on pathogenic mechanism of MMD is in its infancy. MMD is probably a complex and heterogeneous disorder, including different phenotypes and genotypes, in which more than a single factor is implicated. <b><i>Key Message:</i></b> Since the diagnosis of MMD is rapidly increasing worldwide, the development of more efficient stratifying risk systems, including both clinical but also biological drivers became imperative to improve our ability of predict prognosis and to develop mechanism-tailored interventions.
Stroke · 2016
Background and Purpose— Predictors of clinical worsening in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy remain unknown. This study aims to identify demographic, clinical, and magnetic resonance imaging predictors of incident strokes, incident dementia, clinical deterioration, and death in patients with this genetically proven disease. Methods— Two hundred ninety subjects (mean age, 50.6±11.4 years) were assessed at baseline and followed up for 36 months. Incident clinical events were recorded, and clinical scores included the Mini Mental State Examination, Mattis Dementia Rating Scale, modified Rankin Scale, and Barthel index. The number of lacunes and microbleeds, the volume of white-matter hyperintensities, and brain parenchymal fraction were assessed on baseline magnetic resonance imaging. Data were analyzed by ANCOVA, multivariable logistic regression, and Cox proportional hazard models. Results— Incident stroke occurred in 55 of 278 patients (19.8%). Moderate or severe disability developed in 19 of 210 (9%) nondisabled individuals, incident dementia in 49 of 231 (20%) nondemented subjects, and 4.8% of patients died. Active smoking, the number of lacunes, and brain parenchymal fraction independently predicted incident stroke during follow-up. Gait disturbance, dementia, and brain parenchymal fraction predicted progression toward moderate or severe disability. Active smoking, disability, and brain parenchymal fraction predicted incident dementia. Age was the only significant predictor of death. Conclusions— Clinical assessment and brain magnetic resonance imaging aid in predicting incident clinical events and clinical deterioration in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. There is a bidirectional relationship between dementia and moderate or severe disability in predicting each other’s onset. Active smoking is a modifiable risk factor associated with clinical progression in Notch3 mutation carriers.
Cephalalgia : an international journal of headache · 2016
Background and objective Migraine with aura (MA) is a major symptom of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). We assessed the spectrum of migraine symptoms and their potential correlates in a large prospective cohort of CADASIL individuals. Methods A standardized questionnaire was used in 378 CADASIL patients for assessing headache symptoms, trigger factors, age at first attack, frequency of attacks and associated symptoms. MRI lesions and brain atrophy were quantified. Results A total of 54.5% of individuals had a history of migraine, mostly MA in 84% of them; 62.4% of individuals with MA were women and age at onset of MA was lower in women than in men. Atypical aura symptoms were experienced by 59.3% of individuals with MA, and for 19.7% of patients with MA the aura was never accompanied by headache. MA was the inaugural manifestation in 41% of symptomatic patients and an isolated symptom in 12.1% of individuals. Slightly higher MMSE and MDRS scores and lower Rankin score were detected in the MA group. Conclusion MA is observed in almost half of all CADASIL patients. Atypical aura symptoms are reported by more than one in two of them. MA is often inaugural, can remain isolated and is not associated with the severity of the disorder.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Stroke · 2026 · Journal Article
Zhang R, Chen CH, Lambert L, Cheng YW, et al.
European stroke journal · 2025 · Journal Article
Arteaga-Reyes C, Sen D, Rudilosso S, Jouvent E, et al.
Neurology · 2025 · Journal Article
Dammann P, Santos AN, Mavarani L, Guey S, et al.
Theranostics · 2025 · Journal Article
Denis L, Meseguer E, Gaudemer A, Jaklh G, et al.
Neurology · 2025 · Journal Article
Kaisaridi S, Herve D, Jabouley A, Reyes S, et al.
Stroke · 2024 · Journal Article
Di Folco C, Jabouley A, Reyes S, Machado C, et al.
European stroke journal · 2024 · Journal Article
Giroud M, Planton M, Darcourt J, Raposo N, et al.
JAMA network open · 2024 · Journal Article
Aloui C, Neumann L, Bergametti F, Sartori E, et al.
Orphanet journal of rare diseases · 2022 · Journal Article
Yang DD, Rio M, Michot C, Boddaert N, et al.
Annales de biologie clinique · 2021 · Case Reports
Hilaire J, Noizat C, Duong MT, Delrue M, et al.
Journal of medical genetics · 2020 · Journal Article
Bergametti F, Viot G, Verny C, Brechard MP, et al.
Journal of medical genetics · 2020 · Journal Article
Aloui C, Guey S, Pipiras E, Kossorotoff M, et al.
Genetics in medicine : official journal of the American College of Medical Genetics · 2020 · Journal Article
Pinard A, Guey S, Guo D, Cecchi AC, et al.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2019 · Journal Article
Ling Y, De Guio F, Jouvent E, Duering M, et al.
European journal of medical genetics · 2017 · Letter
Quélin C, Loget P, Rozel C, D'Hervé D, et al.
Cerebrovascular diseases (Basel, Switzerland) · 2016 · Journal Article
Bersano A, Guey S, Bedini G, Nava S, et al.
Journal of neurology · 2024 · Journal Article
Giroud M, Calviere L, Machado C, Reyes S, et al.
Cephalalgia : an international journal of headache · 2016 · Journal Article
Guey S, Mawet J, Hervé D, Duering M, et al.
Stroke · 2016 · Journal Article
Chabriat H, Hervé D, Duering M, Godin O, et al.
European journal of neurology · 2025 · Journal Article
Rifino N, Aamodt AH, Wiedmann M, Kramer M, et al.
Cerebrovascular diseases extra · 2024 · Case Reports
Aghetti A, Amsellem T, Hervé D, Chabriat H, et al.
European journal of neurology · 2021 · Journal Article
Mitri F, Bersano A, Hervé D, Kraemer M
European journal of neurology · 2025 · Journal Article
Rifino N, Aamodt AH, Wiedmann M, Kramer M, et al.
International journal of stroke : official journal of the International Stroke Society · 2025 · Journal Article
Rifino N, Hervè D, Acerbi F, Kuroda S, et al.
Journal of Alzheimer's disease : JAD · 2020 · Case Reports
Jouvent E, Alili N, Hervé D, Chabriat H
EClinicalMedicine · 2026 · Journal Article
Chabriat H, Biard L, Guey S, Alili N, et al.
Stroke · 2026 · Journal Article
Hervé D, Lesnik Oberstein SAJ, Pipiras E, Kittner SJ, et al.
Frontiers in neurology · 2019 · Journal Article
Kauv P, Gaudré N, Hodel J, Tuilier T, et al.
Journal of medical genetics · 2017 · Case Reports
Guey S, Grangeon L, Brunelle F, Bergametti F, et al.
Stroke · 2025 · Journal Article
Grosset L, Stepanian A, Labeyrie MA, Civelli V, et al.
European Stroke Organisation (ESO) Guidelines on Moyamoya angiopathy: Endorsed by Vascular European Reference Network (VASCERN)
The European Stroke Organisation (ESO) guidelines on Moyamoya Angiopathy (MMA), developed according to ESO standard operating procedure and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) metho
European Stroke Organisation (ESO) Guidelines on Moyamoya angiopathy: Endorsed by Vascular European Reference Network (VASCERN)
The European Stroke Organisation (ESO) guidelines on Moyamoya Angiopathy (MMA), developed according to ESO standard operating procedure and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) metho
Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).